Light Sidamet Tablet 50/850 Milligrams

Adult dose

This medication is generally taken twice daily with food, gradually increasing the dosage to minimize gastrointestinal adverse reactions caused by metformin. 1. For patients not treated with metformin: The initial dosage is this medication 50/500 mg taken twice daily, 1 tablet per dose, and may be increased to 50/1000 mg taken twice daily, 1 tablet per dose if necessary. 2. For patients treated with metformin: The recommended initial dosage of this medication for those unable to achieve sufficient blood sugar control with metformin monotherapy is sitagliptin 50 mg twice daily (total daily amount 100 mg) along with the existing metformin dosage.

This medication contains sitagliptin and metformin, which help in blood sugar control. There are several precautions to be aware of: First, since there is a risk of hypersensitivity, if symptoms like skin rash, urticaria, or breathlessness occur, discontinue use immediately and consult a doctor. Secondly, there is a risk of acute pancreatitis; therefore, if symptoms such as abdominal pain, nausea, or vomiting occur, inform a doctor immediately. Thirdly, due to the metformin component, there is a rare but potentially fatal side effect called lactic acidosis, so if sudden onset breathlessness, muscle pain, fatigue, or abdominal pain occurs, seek treatment immediately. Fourthly, patients with poor kidney function or those experiencing severe infections or dehydration should not take this medication. Fifthly, this medication should be temporarily discontinued prior to examinations using iodine contrast agents, and can be resumed only after confirming normal kidney function after the examination. Sixthly, pregnant or potentially pregnant women, as well as nursing mothers, should not take this medication. Seventhly, this medication can cause hypoglycemia; therefore, caution should be exercised with irregular meals or vigorous exercise, and patients should closely monitor their blood sugar levels when taken together with other hypoglycemic agents as hypoglycemia symptoms may be more pronounced. Eighthly, patients with liver dysfunction should also avoid taking this medicine and should have regular blood tests and kidney function tests. Lastly, excessive alcohol intake during treatment should be avoided as it may increase the risk of lactic acidosis.

Serious side effects

Urticaria, severe swelling (angioedema), anaphylaxis, severe skin adverse reactions (Stevens-Johnson syndrome, exfoliative dermatitis, blistering similar to pemphigoid), acute pancreatitis, acute renal failure, severe edema, breathlessness (respiratory problems), severe headache, seizures, confusion, visual disturbances, paralysis, severe lactic acidosis, acute or chronic metabolic acidosis, severe edema accompanied by increased blood pressure, severe hypoglycemia, acute cardiovascular events (unstable)

Mild side effects

Diarrhea, nausea, vomiting, abdominal pain, upper respiratory infection, headache, nasopharyngitis, constipation, muscle pain, limb pain, back pain, pruritus, thrombocytopenia, decreased appetite, itching, dizziness, hypoglycemia, joint pain with severe and debilitating symptoms, blistering similar to pemphigoid, elevated serum creatinine, decreased serum vitamin B12

This medication should be stored in a tightly sealed container to avoid air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.

Appearance

Pink oval film-coated tablet with '715' engraved on one side

Package unit

30 tablets/box [(10 tablets/PTP x 3)]